Hypertension and overall survival in metastatic colorectal cancer patients treated with bevacizumab-containing chemotherapy

BACKGROUND: Hypertension (HTN) is a common toxicity of anti-VEGF (vascular endothelial growth factor) antibody treatment. It may be a marker of VEGF signalling pathway inhibition and therefore represent a cancer biomarker in metastatic colorectal cancer (mCRC) patients treated with chemotherapy and...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Päätekijät: Österlund, P, Soveri, L-M, Isoniemi, H, Poussa, T, Alanko, T, Bono, P
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Nature Publishing Group 2011
Aiheet:
Clinical Study
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC3049598/
https://ncbi.nlm.nih.gov/pubmed/21304526
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/bjc.2011.2
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia